KREMEN2 and kidney neoplasm: Moreover, we used a published data set (GSE11482) to confirm that expression of KREMEN2 mRNA in kidney rhabdoid tumors, which are deficient in the SMARCB1 gene, was significantly higher than that in other types of kidney tumor (Supplementary Fig. 2g).